Skip to main content
. 2017 Sep 30;8(50):88021–88033. doi: 10.18632/oncotarget.21406

Table 1. Clinical characteristics of the 78 enrolled patients.

Clinical feature Overall series n. (%) Prospective cohort n. (%) Retrospective cohort n. (%) Statistical significance*
Patients 78 29 49
Age (years)** 47 (18-79) 49 (20-68) 46 (18-79) p=0.460
Sex p=0.351
 M 46 (59%) 15 (52%) 31 (63%)
 F 32 (41%) 14 (48%) 18 (27%)
Sokal risk score p=0.542
 Low 34 (44%) 11 (38%) 23 (47%)
 Intermediate 29 (37%) 12 (42%) 17 (34%)
 High 15 (19%) 6 (20%) 9 (19%)
Eutos risk score p=0.301
 Low 40 (51%) 11 (38%) 29 (59%)
 High 27 (35%) 11 (38%) 16 (33%)
 N/A 11 (14%) 7 (24%) 4 (8%)
Hasford risk score p=0.054
 Low 40 (51%) 11 (38%) 29 (59%)
 Intermediate 26 (34%) 14 (48%) 12 (25%)
 High 12 (15%) 4 (14%) 8 (16%)

Note: *, Students’ t test; **, values are expressed as median (min-max range)